From the aqueous extract (Pc) of Petroselinum crispum (Mill) flat leaves specimens were isolated and identified the flavonoids apigenin (1), apigenin-7-O-glucoside or cosmosiin (2), apigenin-7-O-apiosyl-(1→2)-O-glucoside or apiin (3) and the coumarin 2'',3''-dihydroxyfuranocoumarin or oxypeucedanin hydrate (4). The inhibitory activity toward clotting formation and platelet aggregation was assessed for Pc flavonoids (1) and (2), and the coumarin (4). Pc showed no inhibition on clotting activity when compared with the control. On the other hand, a strong antiplatelet aggregation activity was observed for Pc (IC 50 = 1.81 mg/mL), apigenin (IC 50 = 0.036 mg/mL) and cosmosiin (IC 50 = 0.18 mg/mL). In all cases ADP was used as inductor of platelet aggregation. Our results showed that Pc, apigenin and cosmosiin interfere on haemostasis inhibiting platelet aggregation. To the best of our knowledge this is the first report for the cosmosiin antiplatelet aggregation in vitro activity.
The species Petroselinum crispum, known as parsley, is an aromatic herb from Apiaceae family that has been employed in food, pharmaceutical, perfume and cosmetic industries [1] . Widespread in all continents, parsley may be one of the oldest herbs used as condiment in food. Previous studies on the chemical composition of parsley have revealed the presence of flavonoids [2] [3] [4] [5] , coumarins [6] [7] [8] and terpenes [9, 10] . In popular medicine, parsley is used to treat various illnesses such as Alzheimer's disease, thrombosis and strokes [11, 12] . In Morocco and Brazil, parsley is widely employed against cardiovascular diseases [12] [13] [14] .
The ethnopharmacological knowledge is useful to identify potential therapeutic targets from medicinal plants. Substances from vegetal kingdom, which have already contributed with several compounds in prophylaxis and treatment of a large variety of pathologies, have been investigated for their potential as antithrombotic agents [15, 16] .
Aspirin, an antiplatelet agent and warfarin, an oral anticoagulant were developed from secondary metabolites. However, aspirin consumption can increase the risk of gastrointestinal bleeding and other adverse effects [16] . Antiplatelet and anticoagulant drugs are used to treat cardiovascular diseases and strokes preventing or slowing down blood clots formation and enlargement of existing blood clots. [17] .
According to World Health Organization (WHO), in the next 20 years there will be 24 million deaths from cardiovascular diseases [18] . The current spending with antithrombotic treatment is extremely high [19] . Many antithrombotic substances from synthetic or semi-synthetic origin or derived from natural products are currently under clinical evaluation (phases I, II, III or IV). About 450 substances are considered promising candidates as new antithrombotic drugs in the Stroke Trials Registry [20] . This study led to the isolation of known 5,7,4'-trihydroxyflavone (apigenin), apigenin 7-O-glucoside (cosmosiin), apigenin 7-O-apiosyl-(1→2)-O-glucoside (apiin) and 2'',3''-dihydroxyfuranocoumarin (oxypeucedanin hydrate) identified according to reported NMR data [21, 22] . These flavones and the coumarin derivative were previously described for this species [4, 6] . Two other flavones diosmetin apiosyl-glucoside and diosmetin apiosyl-glucoside isomer were identified with basis on HPLC-DAD chromatogram and comparison with literature data [4] . Apiin is the most abundant flavonoid in parsley, while apigenin is the minor component as reported previously in the literature [3] .
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In experiments assessing the intrinsic pathway (aPTT), and the extrinsic pathway (PT) of coagulation, Pc extract, apigenin, cosmosiin and oxypeucedanin hydrate did not show any significant activity, since the clotting time was not significantly increased. Figures 2, 3 and 4 show the antiplatelet aggregation effect observed for Pc, apigenin and cosmosiin, respectively. A strong antiplatelet aggregation activity was observed for Pc (IC 50 = 1.81 mg/mL), apigenin (IC 50 = 0.036 mg/mL) and cosmosiin (IC 50 = 0.18 mg/mL).
Our results confirm the already known antiplatelet activity reported for Pc and apigenin [12, 23] . Cosmosiin exhibited a significant antiplatelet activity, although less active than apigenin. We can deduce from our findings that the presence of glycosylation decreases the activity of cosmosiin, since the apigenin skeleton is common to both structures [24] .
Studies on the medicinal species P. crispum (Pc) showed that its aerial parts aqueous extract was able to inhibit platelet activity induced by ADP [13] . In these studies, a crude extract at 10 mg/mL inhibited the platelet aggregation by 78%. In our study we observed that Pc leaves extract significantly inhibited (IC 50 = 1.81 mg/mL) the platelet aggregation induced by ADP in human platelet-rich plasma. Moreover, at concentrations 2.6 times lower (3.80 mg/mL) than that used by Mekhfi et al. (2004) we obtained a higher platelet aggregation inhibition (94.4%) [13] .
A possible explanation for the difference in these results should be due to the different extraction procedures employed in both studies. We prepared a decoction from fresh leaves at 10% (w/v), while Mekhfi et al. (2004) prepared an infusion at 5.5% (w/v) without mention if fresh or dried aerial parts were used. The variety of P. crispum was not mentioned by those authors, while we used the flat leaf specimens. Furthermore, other factors such as cultivation conditions, sunlight exposure and season may lead to differences in the production of bioactive secondary metabolites [25] . Flavonoids and other phenolic substances are able to interfere in the platelet system. Apigenin was shown to block the inducer collagen and ADP in platelet-rich plasma [24, 26] . A diet rich in phenolic compounds may favorably contribute for reducing risks of cardiovascular diseases through several mechanisms. Several studies on the cardiovascular protective effect of flavonoids have been reported, suggesting that both apigenin and luteolin may act as competitors with the receptor of thromboxane A 2 (TXA 2 ), an inducer of platelet aggregation [27] .
We can observe that some flavonoids, particularly flavones, may be related to the in vitro inhibitory effect of Phenolic composition of P. crispum and haemostasis Natural Product Communications Vol. 6 (7) 2011 963 platelet aggregation induced by ADP [12, 13] . Our results showed that Pc extract, apigenin and cosmosiin interfere on haemostasis inhibiting platelet aggregation. To the best of our knowledge this is the first report for the cosmosiin in vitro-antiplatelet aggregation activity. The study of apiin and the coumarin oxypeucedanin hydrate effect on the coagulation process is undergoing in our laboratories. For PT tests, 50 µL of pre-warmed plasma was incubated with Pc extract, apigenin, cosmosiin and oxypeucedanin hydrate at various concentrations (suspension in PBS buffer) for 2 min (37°C) and reaction was started by addition of 100 µL of pre-warmed thromboplastin with calcium (PT reagent, BioMériaux, RJ, Brazil). Apiin was not evaluated since it is insoluble in water.
Experimental

Chemical
Platelet aggregation assays: Human blood was collected in EDTA 0.2 M (9:1 v/v). Platelet-rich plasma (PRP) was prepared by centrifugation (500 x g, 10 min) at room temperature. The platelet-poor plasma (PPP) was prepared by centrifugation of the PRP (2000 x g, 10 min) at room temperature). In some cases, experiments were performed using washed platelets as described [28] . Platelet aggregation was monitored by the turbidimetric method on a Chrono-Log aggregometer. PRP (400 µL) was incubated (37°C, 1 min) with continuous stirring at 900 rpm. Platelet aggregation was induced by ADP (2-10 mM). P. crispum extract (Pc), apigenin, cosmosiin and oxypeucedanin hydrate at various concentrations (suspension in PBS buffer) or vehicle (0.5% DMSO v/v) was added to PRP samples 1 min before addition of the agonist.
Supplementary data: Compounds from Petroselinum crispum (Mill.) Nym.ex A.W. Hill, an aromatic herb popularly known as parsley.
